Society for Maternal-Fetal Medicine (SMFM) 2024 Pregnancy Meeting

National Harbor, Maryland 10 February 2024 - 14 February 2024

Breastfeeding delivers long-term cardiometabolic benefits in offspring

27 Feb 2024 by

In a secondary analysis of the HAPO FUS*, breastfeeding was found to be associated with lower rate of glucose metabolism disorders in the offspring; however, this association was not seen among the mothers.

Breastfeeding delivers long-term cardiometabolic benefits in offspring

27 Feb 2024

Maternal transplacental transfer of nipocalimab negligible in foetuses, neonates

23 Feb 2024 by

In the phase II UNITY study, foetuses and neonates whose mums were receiving nipocalimab for early-onset (≤24 weeks gestational age [GA]) severe haemolytic disease of the foetus and newborn (EOS-HDFN) had minimal exposure to the drug.

Maternal transplacental transfer of nipocalimab negligible in foetuses, neonates

23 Feb 2024

Higher aspirin dose may attenuate severe pre-eclampsia risk among high-risk women with obesity

20 Feb 2024 by

Doubling the routine aspirin dose used for pre-eclampsia prevention appears to help lower the risk of developing pre-eclampsia with severe features among high-risk pregnant women with obesity, according to the results of the open-label ASPREO trial.

Higher aspirin dose may attenuate severe pre-eclampsia risk among high-risk women with obesity

20 Feb 2024

Metformin offers no benefit for pre-eclampsia in pregnant women with diabetes

19 Feb 2024 by

Adding metformin to insulin neither lowers the risk of developing preterm pre-eclampsia nor improves the risk markers of cardiovascular disease in pregnant women who have received a diagnosis of diabetes early in pregnancy or have existing type 2 diabetes mellitus, according to a study.

Metformin offers no benefit for pre-eclampsia in pregnant women with diabetes

19 Feb 2024

Revised obstetric VTE prophylaxis protocol prevents wound hematomas

16 Feb 2024 by

Adopting a more conservative approach to venous thromboembolism (VTE) prophylaxis results in reduced rates of wound hematomas, with no increase in postpartum VTE, according to a recent study presented at SMFM 2024.

Revised obstetric VTE prophylaxis protocol prevents wound hematomas

16 Feb 2024

High oxytocin dose helps reduce postpartum haemorrhage

15 Feb 2024 by

Use of high-dose oxytocin postpartum appears to result in reduced rates of postpartum haemorrhage (PPH) when compared with traditional doses, as shown in a study presented at SMFM 2024.

High oxytocin dose helps reduce postpartum haemorrhage

15 Feb 2024